$OMER
OMEROS CORP Stock $omer

$omer Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000162828019002324 Filed on March 01, 2019

Income Statement

Concept	2019 Q1	2018 Q4	2018 Q3
Revenue	$21.78M	$22.02M	$4.608M
YoY Change	1271.47%	60.01%	-78.72%
Cost Of Revenue	$131.0K	$160.0K	$36.00K
YoY Change	-35.47%	-65.96%	-80.43%
Gross Profit	$21.65M	$21.86M	$4.572M
YoY Change	1463.03%	64.48%	-78.71%
Gross Profit Margin	99.4%	99.29%	99.22%
Selling, General & Admin	$14.63M	$14.89M	$13.15M
YoY Change	33.85%	23.77%	11.91%
% of Gross Profit	67.58%	68.12%	287.62%
Research & Development	$26.26M	$25.45M	$26.86M
YoY Change	44.74%	65.37%	81.07%
% of Gross Profit	121.28%	116.42%	587.53%
Depreciation & Amortization	$380.0K	$310.0K	$220.0K
YoY Change	72.73%	82.35%	46.67%
% of Gross Profit	1.76%	1.42%	4.81%
Operating Expenses	$41.02M	$40.49M	$40.05M
YoY Change	40.1%	45.23%	49.62%
Operating Profit	-$19.24M	-$18.47M	-$35.44M
YoY Change	-30.52%	30.83%	593.58%
Interest Expense	$5.600M	-$5.150M	$4.602M
YoY Change	98.23%	80.07%	65.54%
% of Operating Profit
Other Income/Expense, Net	$494.0K	$150.0K	$572.0K
YoY Change	7.39%	-65.12%	40.2%
Pretax Income	-$24.35M	-$36.46M	-$39.47M
YoY Change	-18.97%	120.3%	427.67%
Income Tax		-$12.93M
% Of Pretax Income
Net Earnings	-$24.35M	-$23.53M	-$39.47M
YoY Change	-19.0%	42.19%	427.56%
Net Earnings / Revenue	-111.78%	-106.89%	-856.6%
Basic Earnings Per Share
Diluted Earnings Per Share	-$496.8K	-$480.0K	-$811.3K
COMMON SHARES
Basic Shares Outstanding	49.01M shares	49.01M shares	48.56M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q1	2018 Q4	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.20M	$60.50M	$55.20M
YoY Change	-35.16%	-27.72%	-36.41%
Cash & Equivalents	$4.054M	$5.900M	$2.787M
Short-Term Investments	$43.20M	$54.60M	$52.40M
Other Short-Term Assets	$4.200M	$6.500M	$8.300M
YoY Change	-22.22%	-7.14%	45.61%
Inventory	$736.0K	$88.00K	$214.0K
Prepaid Expenses		$6.463M	$8.334M
Receivables	$24.60M	$22.70M	$2.200M
Other Receivables	$138.0K	$164.0K	$132.0K
Total Short-Term Assets	$76.87M	$89.87M	$66.00M
YoY Change	-2.3%	-17.08%	-44.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.479M	$3.845M	$2.520M
YoY Change	115.23%	81.28%	41.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.400M	$2.200M	$7.100M
YoY Change	-71.08%	-62.07%	22.41%
Total Long-Term Assets	$24.38M	$6.069M	$9.609M
YoY Change	135.48%	-23.72%	26.1%
TOTAL ASSETS
Total Short-Term Assets	$76.87M	$89.87M	$66.00M
Total Long-Term Assets	$24.38M	$6.069M	$9.609M
Total Assets	$101.2M	$95.94M	$75.61M
YoY Change	13.71%	-17.53%	-39.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.121M	$6.281M	$8.847M
YoY Change	-30.07%	-6.13%	140.41%
Accrued Expenses	$34.82M	$30.19M	$15.18M
YoY Change	149.91%	57.83%	-25.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.561M	$889.0K	$560.0K
YoY Change	399.22%	81.43%	52.17%
Total Short-Term Liabilities	$44.51M	$37.36M	$24.59M
YoY Change	80.69%	42.0%	-0.42%
LONG-TERM LIABILITIES
Long-Term Debt	$153.1M	$150.6M	$131.7M
YoY Change	80.04%	79.04%	59.09%
Other Long-Term Liabilities	$24.70M	$8.200M	$8.300M
YoY Change	187.21%	-5.75%	-5.68%
Total Long-Term Liabilities	$177.8M	$158.8M	$131.7M
YoY Change	109.09%	88.78%	59.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.51M	$37.36M	$24.59M
Total Long-Term Liabilities	$177.8M	$158.8M	$131.7M
Total Liabilities	$222.3M	$196.1M	$156.3M
YoY Change	102.7%	77.59%	45.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$674.5M	-$650.1M	-$626.6M
YoY Change	21.87%	24.22%	23.63%
Common Stock	$490.0K	$550.0M	$490.0K
YoY Change	1.45%	114001.45%	2.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$121.0M	-$100.2M	-$89.00M
YoY Change
Total Liabilities & Shareholders Equity	$101.2M	$95.94M	$75.61M
YoY Change	13.71%	-17.53%	-39.76%

Cashflow Statement

Concept	2019 Q1	2018 Q4	2018 Q3
OPERATING ACTIVITIES
Net Income	-$24.35M	-$23.53M	-$39.47M
YoY Change	-19.0%	42.19%	427.56%
Depreciation, Depletion And Amortization	$380.0K	$310.0K	$220.0K
YoY Change	72.73%	82.35%	46.67%
Cash From Operating Activities	-$12.95M	-$24.66M	-$36.87M
YoY Change	14.62%	491.37%	229.2%
INVESTING ACTIVITIES
Capital Expenditures	$182.0K	-$100.0K	-$80.00K
YoY Change	-0.55%		166.67%
Acquisitions
YoY Change
Other Investing Activities	$11.47M	-$2.270M	$33.16M
YoY Change	31.39%	-141.8%	-155.72%
Cash From Investing Activities	$11.29M	-$2.360M	$33.06M
YoY Change	32.06%	-143.46%	-155.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-146.0K	30.09M	3.710M
YoY Change	-126.84%	2610.81%	-94.57%
NET CHANGE
Cash From Operating Activities	-12.95M	-24.66M	-36.87M
Cash From Investing Activities	11.29M	-2.360M	33.06M
Cash From Financing Activities	-146.0K	30.09M	3.710M
Net Change In Cash	-1.807M	3.070M	-100.0K
YoY Change	-18.05%	29.54%	-95.76%
FREE CASH FLOW
Cash From Operating Activities	-$12.95M	-$24.66M	-$36.87M
Capital Expenditures	$182.0K	-$100.0K	-$80.00K
Free Cash Flow	-$13.13M	-$24.56M	-$36.79M
YoY Change	14.38%	488.97%	229.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001285819
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49011735	shares
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	827171756	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	OMEROS CORP
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018	dei	Trading Symbol TradingSymbol	OMER
CY2017Q4	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	1026000	USD
CY2018Q4	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	820000	USD
CY2017Q4	omer	Accrued Contract Research Costs AccruedContractResearchCosts	4251000	USD
CY2018Q4	omer	Accrued Contract Research Costs AccruedContractResearchCosts	12012000	USD
CY2018	omer	Adjustmentsto Additional Paidin Capital Convertible Debt Premiums Paid AdjustmentstoAdditionalPaidinCapitalConvertibleDebtPremiumsPaid	33180000	USD
CY2017Q4	omer	Advanced Payments Noncurrent AdvancedPaymentsNoncurrent	0	USD
CY2018Q4	omer	Advanced Payments Noncurrent AdvancedPaymentsNoncurrent	1070000	USD
CY2018Q2	omer	Classof Warrantor Right Period ClassofWarrantorRightPeriod	P5Y
CY2018Q4	omer	Deferred Tax Assets Valuation Allowance Percentage DeferredTaxAssetsValuationAllowancePercentage	1
CY2017Q4	omer	Deferred Tax Liabilities Equity Component Of Convertible Debt DeferredTaxLiabilitiesEquityComponentOfConvertibleDebt	0	USD
CY2018Q4	omer	Deferred Tax Liabilities Equity Component Of Convertible Debt DeferredTaxLiabilitiesEquityComponentOfConvertibleDebt	12706000	USD
CY2017Q4	omer	Hospital Return Liability Current HospitalReturnLiabilityCurrent	2350000	USD
CY2018Q4	omer	Hospital Return Liability Current HospitalReturnLiabilityCurrent	0	USD
CY2018Q4	omer	Long Term Purchase Commitment Termination Fee LongTermPurchaseCommitmentTerminationFee	11600000	USD
CY2018Q4	omer	Net Operating Leases Future Minimum Payments Due NetOperatingLeasesFutureMinimumPaymentsDue	52139000	USD
CY2018Q4	omer	Net Operating Leases Future Minimum Payments Due Current NetOperatingLeasesFutureMinimumPaymentsDueCurrent	4803000	USD
CY2018Q4	omer	Net Operating Leases Future Minimum Payments Due In Five Years NetOperatingLeasesFutureMinimumPaymentsDueInFiveYears	6348000	USD
CY2018Q4	omer	Net Operating Leases Future Minimum Payments Due In Four Years NetOperatingLeasesFutureMinimumPaymentsDueInFourYears	6203000	USD
CY2018Q4	omer	Net Operating Leases Future Minimum Payments Due In Three Years NetOperatingLeasesFutureMinimumPaymentsDueInThreeYears	6061000	USD
CY2018Q4	omer	Net Operating Leases Future Minimum Payments Due In Two Years NetOperatingLeasesFutureMinimumPaymentsDueInTwoYears	5926000	USD
CY2018Q4	omer	Net Operating Leases Future Minimum Payments Due Thereafter NetOperatingLeasesFutureMinimumPaymentsDueThereafter	22798000	USD
CY2018Q4	omer	Net Working Capital Adjustments NetWorkingCapitalAdjustments	52500000	USD
CY2016	omer	Noncash Transaction Conversion Of Accrued Interest Into Notes Payable NoncashTransactionConversionOfAccruedInterestIntoNotesPayable	516000	USD
CY2017	omer	Noncash Transaction Conversion Of Accrued Interest Into Notes Payable NoncashTransactionConversionOfAccruedInterestIntoNotesPayable	3315000	USD
CY2018	omer	Noncash Transaction Conversion Of Accrued Interest Into Notes Payable NoncashTransactionConversionOfAccruedInterestIntoNotesPayable	3408000	USD
CY2018Q4	omer	Operating And Capital Lease Future Minimum Payments Due OperatingAndCapitalLeaseFutureMinimumPaymentsDue	55196000	USD
CY2018Q4	omer	Operating And Capital Lease Future Minimum Payments Due Next Twelve Months OperatingAndCapitalLeaseFutureMinimumPaymentsDueNextTwelveMonths	5977000	USD
CY2018Q4	omer	Operating And Capital Lease Future Minimum Payments Due Thereafter OperatingAndCapitalLeaseFutureMinimumPaymentsDueThereafter	22798000	USD
CY2018Q4	omer	Operating And Capital Lease Future Minimum Payments Due Year Five OperatingAndCapitalLeaseFutureMinimumPaymentsDueYearFive	6443000	USD
CY2018Q4	omer	Operating And Capital Lease Future Minimum Payments Due Year Four OperatingAndCapitalLeaseFutureMinimumPaymentsDueYearFour	6455000	USD
CY2018Q4	omer	Operating And Capital Lease Future Minimum Payments Due Year Three OperatingAndCapitalLeaseFutureMinimumPaymentsDueYearThree	6642000	USD
CY2018Q4	omer	Operating And Capital Lease Future Minimum Payments Due Year Two OperatingAndCapitalLeaseFutureMinimumPaymentsDueYearTwo	6881000	USD
CY2016	omer	Payments For Premium Paidfor Capped Call Option PaymentsForPremiumPaidforCappedCallOption	0	USD
CY2017	omer	Payments For Premium Paidfor Capped Call Option PaymentsForPremiumPaidforCappedCallOption	0	USD
CY2018	omer	Payments For Premium Paidfor Capped Call Option PaymentsForPremiumPaidforCappedCallOption	33180000	USD
CY2016	omer	Sales Agreement Net Proceeds SalesAgreementNetProceeds	7000	USD
CY2018	omer	Sales Agreement Net Proceeds SalesAgreementNetProceeds	1424000	USD
CY2018Q4	omer	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumber	2844332	shares
CY2017	omer	Tax Cutsand Jobs Act Changein Tax Rate Deferred Tax Liability Income Tax Benefit TaxCutsandJobsActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit	61300000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6691000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6281000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	17079000	USD
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	22654000	USD
CY2017Q4	us-gaap	Accrued Exchange Fee Rebate Current AccruedExchangeFeeRebateCurrent	6561000	USD
CY2018Q4	us-gaap	Accrued Exchange Fee Rebate Current AccruedExchangeFeeRebateCurrent	8075000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19126000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30186000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1627000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3669000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3283000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4245000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	520072000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	549479000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	12929000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	13582000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	12688000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	11713000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	758000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	55655000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	672000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	328000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	2500000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13582000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12688000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11713000	USD
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9909976	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9757861	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10556253	shares
CY2017Q4	us-gaap	Assets Assets	116328000	USD
CY2018Q4	us-gaap	Assets Assets	95936000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	108372000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	89867000	USD
CY2017Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	80355000	USD
CY2018Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	54637000	USD
CY2016	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	404000	USD
CY2017	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1141000	USD
CY2018	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	2118000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	810000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1578000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	3057000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	1174000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	95000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	252000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	581000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	955000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments1 CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1	2400000	USD
CY2017Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	530000	USD
CY2018Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	1200000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1365000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2224000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3394000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5861000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	859000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1170000	USD
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2467000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	60500000	USD
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.94
CY2018Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	23.00
CY2018Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.94
CY2018Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	43115	shares
CY2018Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	200000	shares
CY2018Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	100602	shares
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48211226	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49011684	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48211226	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49011684	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	482000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	490000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-66745000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53481000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-126757000	USD
CY2016	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1412000	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1078000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	512000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016Q4	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	198000	USD
CY2018Q4	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	439000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-11261000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12929000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	12857000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8718000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8177000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1668000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	131957000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	171237000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	131947000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	158380000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	90498000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	113928000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	68900000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	125000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4759000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	10564000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	26748000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	35739000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7829000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8969000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	2123000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	2037000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	131947000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	158380000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	10000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	151000	USD
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.04
CY2018	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	4000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	300000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	551000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	962000	USD
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.65
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.33
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2017Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.17
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.62
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.81
CY2018Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.61
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.09
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.37
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.60
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.19
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.00
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	1.15
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.00
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.03
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.08
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.00
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.04
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.11
CY2016	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	37000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.05
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2309000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2714000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	334300000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P8Y9M11D
CY2016	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	354000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5595000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12993000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	43782000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	52044000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51718000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-66745000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-53481000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-139686000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12929000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-421000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9616000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10544000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	656000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-685000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-355000	USD
CY2017	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-96000	USD
CY2018	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-435000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-347000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5270000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	498000	USD
CY2016	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5520000	USD
CY2017	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5107000	USD
CY2018	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5674000	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-4844000	USD
CY2017	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2018	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-4681000	USD
CY2016	us-gaap	Interest Expense InterestExpense	7819000	USD
CY2017	us-gaap	Interest Expense InterestExpense	11030000	USD
CY2018	us-gaap	Interest Expense InterestExpense	16252000	USD
CY2016	us-gaap	Interest Paid InterestPaid	5293000	USD
CY2017	us-gaap	Interest Paid InterestPaid	6895000	USD
CY2018	us-gaap	Interest Paid InterestPaid	8896000	USD
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1677000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	443000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	88000	USD
CY2016	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	313000	USD
CY2017	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	549000	USD
CY2018	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	187000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116328000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95936000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26307000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37356000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	490000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	889000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	68698000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	74995000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81053000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16335000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37598000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25151000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-51504000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-36227000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-103737000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-66745000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-15089000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-14359000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-7482000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-16551000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-53481000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-30054000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-33696000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-39472000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-23534000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-126757000	USD
CY2017Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	83307000	USD
CY2018Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	0	USD
CY2018	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2016	us-gaap	Operating Expenses OperatingExpenses	95893000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	24982000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	29090000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	26768000	USD
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	27881000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	108721000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	29277000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	32272000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	40050000	USD
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	40491000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	142090000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-54276000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12725000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11939000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5110000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-14121000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-43895000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27689000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-30617000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-35442000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-18474000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-112222000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	52697000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	5361000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	558000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	6348000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	6203000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6061000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5926000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	22798000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	558000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	0	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	0	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	0	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	0	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	0	USD
CY2016	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	737000	USD
CY2017	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	886000	USD
CY2018	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	848000	USD
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	414500000	USD
CY2018Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	513200000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1002000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1219000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	945000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1444000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1781000	USD
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	65000	USD
CY2018Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	164000	USD
CY2016	us-gaap	Paid In Kind Interest PaidInKindInterest	1977000	USD
CY2017	us-gaap	Paid In Kind Interest PaidInKindInterest	4187000	USD
CY2018	us-gaap	Paid In Kind Interest PaidInKindInterest	5635000	USD
CY2016	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	5700000	USD
CY2017	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2018	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	11902000	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1501000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6800000	USD
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	73966000	USD
CY2017	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	65326000	USD
CY2018	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	68782000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	126000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	350000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	567000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7036000	USD
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6463000	USD
CY2016Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37300000	USD
CY2017Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	63600000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	38039000	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	63657000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	100000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	44550000	USD
CY2017	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	28078000	USD
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	94500000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3153000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11769000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6732000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5404000	USD
CY2016	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	210000000	USD
CY2016	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	57757000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8090000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2121000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3845000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	17144000	USD
CY2018Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	22818000	USD
CY2016	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations		USD
CY2017	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	431000	USD
CY2018	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	951000	USD
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	70137000	USD
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	132077000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50699000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55599000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89860000	USD
CY2017Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	5835000	USD
CY2018Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	1154000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-523368000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-650125000	USD
CY2016	us-gaap	Revenues Revenues	41617000	USD
CY2017Q1	us-gaap	Revenues Revenues	12257000	USD
CY2017Q2	us-gaap	Revenues Revenues	17151000	USD
CY2017Q3	us-gaap	Revenues Revenues	21658000	USD
CY2017Q4	us-gaap	Revenues Revenues	13760000	USD
CY2017	us-gaap	Revenues Revenues	64826000	USD
CY2018Q1	us-gaap	Revenues Revenues	1588000	USD
CY2018Q2	us-gaap	Revenues Revenues	1655000	USD
CY2018Q3	us-gaap	Revenues Revenues	4608000	USD
CY2018Q4	us-gaap	Revenues Revenues	22017000	USD
CY2018	us-gaap	Revenues Revenues	29868000	USD
CY2017Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	0	USD
CY2018Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	148981000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	13582000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	12688000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	11713000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.74
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.74
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.78
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0163
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0205
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0268
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7468806	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.21
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13600000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	16400000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11356000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	469929	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.42
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1891757	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.89
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.66
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.32
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11319000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9657259	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10313138	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.39
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.22
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	11283000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	10005615	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	11.13
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.79
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	15.01
CY2017	us-gaap	Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued	25000	shares
CY2018	us-gaap	Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued	20000	shares
CY2016Q3	us-gaap	Share Price SharePrice	11.50
CY2017Q3	us-gaap	Share Price SharePrice	22.75
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y0M3D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10984000	USD
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M3D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M27D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y4M2D
CY2016	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	758000	USD
CY2017	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	0	USD
CY2018	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	1424000	USD
CY2016Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3500000	shares
CY2017Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3000000	shares
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	765949	shares
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37314000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	63657000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3146000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11769000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6732000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-26234000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-37447000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-2814000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-100156000	USD
CY2017	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2018	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	24900000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-32000000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-26400000	USD
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40446410	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	45539362	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48582636	shares
CY2018	us-gaap	Advertising Cost Policy Expensed Advertising Cost AdvertisingCostPolicyExpensedAdvertisingCost	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advertising costs, which we consider to be media and marketing materials, are expensed as incurred and were </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">, $</font><font style="font-family:inherit;font-size:10pt;">328,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$672,000</font><font style="font-family:inherit;font-size:10pt;"> during the years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;padding-left:24px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Major Suppliers</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We use a single contract manufacturer to supply the OMIDRIA drug substance and a separate company to perform final packaging of OMIDRIA for commercial sale. We generally use one to two contract manufacturers to produce clinical trial material for each of our clinical trials, which creates a concentration of risk for us.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We endeavor to maintain reasonable levels of drug supply for our commercial and clinical trial use and other manufacturers are available should we need to change suppliers. A change in suppliers, however, could cause a delay in delivery of OMIDRIA or our clinical trial material that would adversely affect our business. </font></div></div>
CY2018	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Organization</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system, and immune-related diseases, including cancers. Our first drug product, OMIDRIA, is marketed in the United States (U.S.) for use during cataract surgery or intraocular lens replacement. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

Files In Submission

Name	View Source	Status
0001628280-19-002324-index-headers.html	Edgar Link	pending
0001628280-19-002324-index.html	Edgar Link	pending
0001628280-19-002324.txt	Edgar Link	pending
0001628280-19-002324-xbrl.zip	Edgar Link	pending
chart-32831c0b5e1359fd91ca01.jpg	Edgar Link	pending
chart-b1303fbd031b42c0087a01.jpg	Edgar Link	pending
exhibite.jpg	Edgar Link	pending
exhibitf.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
omer-20181231.xml	Edgar Link	completed
omer-20181231.xsd	Edgar Link	pending
omer-20181231x10k.htm	Edgar Link	pending
omer-20181231_cal.xml	Edgar Link	unprocessable
omer-20181231_def.xml	Edgar Link	unprocessable
omer-20181231_lab.xml	Edgar Link	unprocessable
omer-20181231_pre.xml	Edgar Link	unprocessable
omer-ex1019_20181231.htm	Edgar Link	pending
omer-ex231_20181231.htm	Edgar Link	pending
omer-ex311_20181231.htm	Edgar Link	pending
omer-ex312_20181231.htm	Edgar Link	pending
omer-ex321_20181231.htm	Edgar Link	pending
omer-ex322_20181231.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OMER
OMEROS CORP Stock $omer

2019 Q1 Form 10-K Financial Statement

#000162828019002324 Filed on March 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER OMEROS CORP Stock $omer

2019 Q1 Form 10-K Financial Statement

#000162828019002324 Filed on March 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER
OMEROS CORP Stock $omer